← All claims

Diets

dietary glycemic load increases type-2 diabetes risk

In plain terms: Do blood-sugar-spiking carbs raise your diabetes risk?

Strong support Diets
RefutedContestedStrong support
consensus score 0.74

Yes — strong evidence of a real causal link, though it comes from population studies, not trials.

📅 Last reviewed: 2026-07-15 ⓘ

Evidence ladder

How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."

Top evidence so far: All trials, pooled (Meta-analysis)

MechanismIn-vitroAnimalObservationalRCTMeta-analysis

How the studies fall

9 support 0 contradict 0 tested null 3 mixed · 12 sources, 8 independent groups

What the evidence shows

High dietary glycemic load independently raises T2D risk (Bradford-Hill-assessed causal), and the authors argue fiber/whole-grain cannot substitute for low GI/GL — held in deliberate tension with the fiber/whole-grain evidence. Note GI-advocacy author-panel allegiance.

The evidence (14)

SourceGradeStanceQualityFinding
Li Y, Hruby A, Bernstein AM, Ley SH, Wang DD, Chiuve SE, Sampson L, Rexrode KM, Rimm EB, Willett WC, Hu FB
2015 · J Am Coll Cardiol
observational mixed high High-GL carbohydrate sources relate to CHD risk; relevant carb-quality cohort evidence, T2D-adjacent but not direct null.
Jayedi A, Soltani S, Jenkins D, Sievenpiper J, Shab-Bidar S
2022 · Crit Rev Food Sci Nutr
meta-analysis supports moderate Umbrella review whose units are meta-analyses: 'Eighteen meta-analyses of prospective cohort studies, reporting 19 SRRs for dietary GI and 17 SRRs for dietary GL were identified'; GL positively associated with T2D, GRADE certainty very low to low. Recalculating other meta-analyses' SRRs adds no independent observation — review, zero weight.
Bhupathiraju SN, Tobias DK, Malik VS, Pan A, Hruby A, Manson JE, Willett WC, Hu FB
2014 · Am J Clin Nutr
observational supports high Three large US cohorts + updated meta-analysis: higher GI/GL associated with elevated incident type-2 diabetes risk.
Salmerón J, Manson JE, Stampfer MJ, Colditz GA, Wing AL, Willett WC
1997 · JAMA
observational supports moderate NHS: high-GL/low-cereal-fiber diet raised incident NIDDM
Livesey G, Taylor R, Livesey HF, Buyken AE, Jenkins DJA, Augustin LSA, Sievenpiper JL, Barclay AW, Liu S, Wolever TMS, Willett WC, Brighenti F, Salas-Salvadó J, Björck I, Rizkalla SW, Riccardi G, Vecchia CL, Ceriello A, Trichopoulou A, Poli A, Astrup A, Kendall CWC, Ha MA, Baer-Sinnott S, Brand-Miller JC
2019 · Nutrients
meta-analysis supports moderate Dose-response cohort MA + Bradford-Hill: GI/GL causal for T2D; fiber not a surrogate (allegiance caveat)
Willett W, Manson J, Liu S
2002 · Am J Clin Nutr
observational supports moderate Narrative review, no new data: 'several lines of evidence have collectively provided strong support for a relation between such diets and diabetes incidence' and 'In large prospective epidemiologic studies, both the glycemic index and the glycemic load ... have been associated with a greater risk of type 2 diabetes'. Re-describes the authors' own cohorts - zero weight.
Livesey G, Taylor R, Livesey H, Liu S
2013 · Am J Clin Nutr
meta-analysis supports moderate Dose-response meta-analysis confirms positive GL-T2D relation once heterogeneity sources controlled.
Greenwood DC, Threapleton DE, Evans CE, Cleghorn CL, Nykjaer C, Woodhead C, Burley VJ
2013 · Diabetes Care
meta-analysis supports moderate Dose-response meta-analysis of prospective cohorts: higher GI and GL raise type-2 diabetes risk.
Dong JY, Zhang L, Zhang YH, Qin LQ
2011 · Br J Nutr
meta-analysis supports moderate Meta-analysis of 13 cohorts: high GL RR 1.20 and high GI RR 1.16 for type-2 diabetes.
Barclay AW, Petocz P, McMillan-Price J, Flood VM, Prvan T, Mitchell P, Brand-Miller JC
2008 · Am J Clin Nutr
meta-analysis supports moderate Meta-analysis of observational studies links high GI/GL to type-2 diabetes and other chronic disease risk.
Reynolds A, Mann J, Cummings J, Winter N, Mete E, Te Morenga L
2019 · Lancet
meta-analysis mixed high WHO-commissioned SR/MA series (185 cohorts, 58 trials). On GI/GL the abstract states only: 'Smaller or no risk reductions were found with the observational data when comparing the effects of diets characterised by low rather than higher glycaemic index or load', certainty 'low to very low' for GI/GL vs 'moderate' for fibre. The T2D-specific GL estimate is not in the abstract, so whether it is a small real reduction or a null cannot be told; kept mixed. Bears against the claim's scope that GI/GL is the stronger independent lever. [abstract-grade]
⚠️ correction-on-file (Crossref) - kept, corrigendum not retraction
Livesey G, Taylor R, Livesey HF, Buyken AE, Jenkins DJA, Augustin LSA, Sievenpiper JL, Barclay AW, Liu S, Wolever TMS, Willett WC, Brighenti F, Salas-Salvadó J, Björck I, Rizkalla SW, Riccardi G, Vecchia C, Ceriello A, Trichopoulou A, Poli A, Astrup A, Kendall CWC, Ha MA, Baer-Sinnott S, Brand-Miller JC
2019 · Nutrients
meta-analysis supports moderate All nine Bradford-Hill criteria met for GI/GL as causal contributors to incident type-2 diabetes.
Lai H, Sun M, Liu Y, Zhu H, Li M, Pan B, Wang Q, Yang Q, Cao X, Tian C, Lu Y, Song X, Ding G, Tian J, Yang K, Ge L
2023 · Crit Rev Food Sci Nutr
meta-analysis supports moderate Dose-response cohort MA: high-GL white rice raises T2D risk 18%; +6% per 150 g/day
Ha AW
2026 · Nutrition research and practice
observational mixed moderate Korean Ansan/Anseong cohort, 19-yr follow-up (73,545 person-yrs), 761 incident T2D; highest fruit-intake quartile HR 1.45 (95% CI 1.04-2.03) for T2D in females, but fruit-GL association only borderline (HR 1.36, 95% CI 0.98-1.91, p=0.058).

Disagree, or know a study we missed?

We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.

📚 Suggest a study ⚑ Flag / request reclassification

Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).

Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.